Connor, Clark & Lunn Investment Management (CC&L)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.49M | Buy |
|
|||||
|
2024
Q4 | $918K | Buy |
|
|||||
|
2024
Q3 | $473K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $4.39M | Sell |
|
|||||
|
2023
Q1 | $4.56M | Sell |
|
|||||
|
2022
Q4 | $4.41M | Buy |
|
|||||
|
2022
Q3 | $2.32M | Buy |
|
|||||
|
2022
Q2 | $1.73M | Buy |
|
|||||
|
2022
Q1 | $1.41M | Sell |
|
|||||
|
2021
Q4 | $3.12M | Buy |
|
|||||
|
2021
Q3 | $2.38M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $793K | Buy |
|
|||||
|
2020
Q4 | $406K | Buy |
|